1460885372-1e485ea7-045a-41d5-b5f3-3124b2afec1b

1. A method for analyzing a blood sample quiescently residing within an analysis chamber defined by a first panel and a second panel, both of which panels are transparent, which sample has one or more first constituents and one or more second constituents, and which second constituents are different from the first constituents, and which sample is mixed with a colorant that causes the first constituents and the second constituents to fluoresce upon exposure to predetermined first wavelengths of light, and which colorant is also operative to absorb light at one or more predetermined second wavelengths of light, the method comprising the steps of:
illuminating at least a portion of the sample containing the first constituents and the second constituents at the first wavelengths and at the second wavelengths;
imaging the at least a portion of the sample, including producing image signals indicative of fluorescent emissions from the first constituents and the second constituents and image signals indicative of the optical density of the first constituents and the second constituents;
determining one or more fluorescent emission values for each the first constituents and second constituents using the image signals;
determining one or more optical density values for each of the first constituents and second constituents using the image signals; and
identifying the first constituents and the second constituents using the determined fluorescent emission values and the determined optical density values.
2. The method of claim 1, wherein the blood sample is substantially undiluted whole blood.
3. The method of claim 1, wherein the first and second constituents are selected from the group consisting of white blood cells and particulates.
4. The method of claim 3, wherein the first and second constituents are each types of white blood cells.
5. The method of claim 4, wherein the first constituents and the second constituents are selected from the group consisting of eosinophils, neutrophils, and basophils.
6. The method of claim 3, wherein the first and second constituents are each types of particulates.
7. The method of claim 6, wherein the first and second particulates are selected from a group consisting of platelets and hematoparasites.
8. A method for analyzing a blood sample residing within an analysis chamber defined by a first panel and a second panel, which sample has one or more first constituents and one or more second constituents, and which second constituents are different from the first constituents, the method comprising the steps of:
imaging at least a portion of the sample containing the first constituents and the second constituents at the first wavelengths and at the second wavelengths, which sample is mixed with a colorant that causes the first constituents and the second constituents to fluoresce upon exposure to one or more first wavelengths of light, and which colorant is also operative to absorb light at one or more second wavelengths of light, the imaging including producing image signals representative of fluorescent emissions from the sample and image signals representative of the optical density of the sample;
determining one or more values representative of fluorescent emission from the first constituents and second constituents using the image signals;
determining one or more values representative of optical density for the first constituents and second constituents using the image signals; and
distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values.
9. The method of claim 8, wherein the first and second constituents are selected from the group consisting of white blood cells and particulates.
10. The method of claim 9, wherein the first and second constituents are each types of white blood cells.
11. The method of claim 10, wherein the first constituents and the second constituents are selected from the group consisting of eosinophils, neutrophils, and basophils.
12. The method of claim 9, wherein the first and second constituents are each types of particulates.
13. The method of claim 12, wherein the first and second particulates are selected from a group consisting of platelets and hematoparasites.
14. The method of claim 8, wherein the one or more one or more values representative of fluorescent emission from the first constituents and the second constituents are determined on a per pixel basis.
15. The method of claim 8, wherein the one or more one or more values representative of optical density of the first constituents and the second constituents are determined on a per pixel basis.
16. The method of claim 8, wherein the step of distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values includes determining a ratio of the determined fluorescent emission representative values and the determined optical density representative values for a particular cell.
17. The method of claim 8, wherein the step of distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values, includes comparing the determined optical density representative values for one or more of the constituents to a predetermined optical density value.
18. The method of claim 8, wherein the step of distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values utilizes the fluorescent emissions representative values and the optical density representative values of only a cytoplasmic region of the first constituents and second constituents.
19. The method of claim 8, wherein the step of distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values includes comparing the fluorescent emission representative values of substantially all constituents within the imaged sample.
20. The method of claim 8, wherein the step of distinguishing the first constituents from the second constituents using the determined fluorescent emission representative values and the determined optical density representative values includes identifying both the first constituents and second constituents.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A composition for stabilizing and protecting micronutrients, phytochemicals, nutraceuticals, and other beneficial compounds and nutrients, comprising:
vegetable gums;
oligosaccharides; and
whey proteins.
2. The composition of claim 1, where the vegetable gum is selected from the group consisting of: gellan, xanthan, carrageenan, and combinations and mixtures thereof.
3. The composition of claim 1, where the composition comprises about 1% to about 10% by weight vegetable gums.
4. The composition of claim 1, where the composition comprises about 5% to about 10% by weight oligosaccharides.
5. The composition of claim 1, where the composition comprises about 5% to about 10% by weight whey proteins.
6. A process for stabilizing and protecting food additives or food articles comprising applying the composition of claim 1 to the food additives or food articles.
7. A process for producing a food additive comprising:
shredding a food article;
sanitizing the food article;
applying a composition of claim 1 to the food article;
freeze drying the food article; and
grinding the food article into a powder to form a food additive.
8. The process of claim 7, where the food article is a fruit or vegetable.
9. The process of claim 7, where shredding the food article comprises slicing, cutting, chopping, cubing, mincing, or dicing the food article to about 6.2 mm (0.25 inches) particle size.
10. The process of claim 7, where sanitizing the food article comprises spraying a solution of about 1 ppm chlorine on the food article.
11. The process of claim 7, where applying a composition of claim 1 to the food article comprises spraying a liquid solution or dusting a dry mixture of the composition of claim 1 on the food article.
12. The process of claim 7, where freeze drying the food article comprises:
introducing the food article at about 0\xb0 C. (32\xb0 F.) to a freeze dryer;
lowering the pressure in the freeze dryer to about 500 micron Hg (0.5 torr);
maintaining the lowered pressure for about 8 to about 12 hours; and
gradually raising the temperature to about 30\xb0 C. (86\xb0 F.).
13. The process of claim 7, where freeze drying the food article reduces the moisture content of the food article to between about 2% and about 5%.
14. The process of claim 7, where grinding the food article comprises pulverizing, crushing, or pounding the food article to form a powder of about 60 mesh to about 100 mesh size.